Tag: Infliximab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Infliximab

Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies

Added to Collection on: 2024-12-14 22:31:52

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Disease-modifying antirheumatic drugs
Janssen Biotech
Orphan drugs
Ustekinumab
Vedolizumab
Infliximab
Adalimumab
Immunoglobulin E
Hypersensitivity
Alpha-gal syndrome

Click the tags to see associated articles and topics

View Article Details
Long-Term TNFi Use Does Not Increase Overall Cancer Risk in Psoriasis

Added to Collection on: 2025-01-14 23:38:28

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Psoriasis
TNF inhibitors
Autoimmune diseases
Infliximab
Adalimumab
Psoriatic arthritis
Etanercept
Joel Gelfand
Psoriatic onychodystrophy

Click the tags to see associated articles and topics

View Article Details
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025 - openPR.com

Added to Collection on: 2025-02-20 12:12:36

Tags for this article:

Specialty drugs
Orphan drugs
Immunosuppressants
Monoclonal antibodies
Biotechnology
Biosimilar
Biopharmaceutical
Adalimumab
Biocon
Infliximab
Celltrion
Trastuzumab

Click the tags to see associated articles and topics

View Article Details
Biosimilars Market Products, Applications and Regulations Overview 2024-2025 & 2030

Added to Collection on: 2025-03-06 11:49:17

Tags for this article:

Immunosuppressants
Specialty drugs
Biotechnology
Monoclonal antibodies
TNF inhibitors
Biopharmaceutical
Biosimilar
Adalimumab
Pharmaceutical industry in India
Novartis
Lupin Limited
Infliximab
Epoetin

Click the tags to see associated articles and topics

View Article Details
RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program ... - Placera

Added to Collection on: 2025-03-12 23:14:18

Tags for this article:

Autoimmune diseases
Immunosuppressants
Monoclonal antibodies
Crohn's disease
Abdominal pain
Infliximab
Inflammatory bowel disease
Clinical trial
United States

Click the tags to see associated articles and topics

View Article Details
Biosimilar Monoclonal Antibodies Market Know the Scope and Trends - openPR.com

Added to Collection on: 2025-05-16 14:59:59

Tags for this article:

Monoclonal antibodies
Orphan drugs
Specialty drugs
Immunosuppressants
Immunology
Biosimilar
Adalimumab
Biopharmaceutical
Infliximab
Rituximab
Trastuzumab
Bevacizumab
Denosumab
Cetuximab
Ranibizumab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
MHC-Associated Peptide Proteomics (MAPPs) as a Tool for Assessment of Immunogenicity ...

Added to Collection on: 2025-08-17 23:18:45

Tags for this article:

Immune system
Glycoproteins
Immunology
Single-pass transmembrane proteins
Genes
Immunogenicity
Major histocompatibility complex
Human leukocyte antigen
MHC class I
Antigen
HLA-A
HLA-B
Infliximab
Karle
J. R. MAPPs

Click the tags to see associated articles and topics

View Article Details
Ankylosing Spondylitis Market Size to Hit USD 11.15 Billion - GlobeNewswire

Added to Collection on: 2025-08-21 13:53:46

Tags for this article:

Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Disease-modifying antirheumatic drugs
Biotechnology
Biopharmaceutical
Ankylosing spondylitis
Adalimumab
Etanercept
Biosimilar
Infliximab
Spondyloarthritis

Click the tags to see associated articles and topics

View Article Details
Johnson and Johnson Discontinues Development of Nipocalimab in Combination with Anti ...

Added to Collection on: 2025-09-03 17:44:59

Tags for this article:

Monoclonal antibodies
Biotechnology
Rheumatology
Autoimmune diseases
Connective tissue diseases
TNF inhibitor
Rheumatoid arthritis
Arthritis
Sjögren's disease
Biopharmaceutical
Infliximab
Biological therapy for inflammatory bowel disease
Johnson and Johnson

Click the tags to see associated articles and topics

View Article Details
FDA Approves Johnson & Johnson's Simponi for Pediatric Ulcerative Colitis

Added to Collection on: 2025-10-08 16:37:32

Tags for this article:

Monoclonal antibodies
Janssen Biotech
TNF inhibitors
Autoimmune diseases
Golimumab
Immunology
Ulcerative colitis
Clinical trial
Infliximab
Johnson & Johnson
Adobe
Simponi

Click the tags to see associated articles and topics

View Article Details
Book a Demo